KAUST’s NanoRanger provides quick, precise diagnosis of Mendelian genetic disorders, identifying critical genetic breakpoints efficiently.
Despite rapid advances in genetic testing in recent decades, more than half of people worldwide with suspected Mendelian genetic disorders do not have an accurate molecular diagnosis. Others endure more than six years of tests before a diagnosis is given. Now, KAUST researchers and scientists across